AstraZeneca

FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Fierce Pharma
Wed, 04/19/17 - 04:12 pm
FDA
AstraZeneca
ZS-9
ZS Pharma
hyperkalemia
A final flop signals the bitter end to Circassia’s big plans for allergy R&D
Endpoints
Tue, 04/18/17 - 09:34 am
Circassia
R&D
allergies
AstraZeneca
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
Fierce Pharma
Tue, 04/11/17 - 10:03 am
AstraZeneca
opioid-induced constipation
opioids
FDA Approves Astra's Lung Cancer Drug
Investopedia
Fri, 03/31/17 - 10:09 pm
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
AstraZeneca Shares Progress on LYNPARZA™ (olaparib) Tablets in the US
Yahoo
Wed, 03/29/17 - 09:05 am
AstraZeneca
Lynparza
olaparib
ovarian cancer
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
Mon, 03/27/17 - 09:38 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
What to Expect from AstraZeneca’s Farxiga in 2017
Market Realist
Thu, 03/23/17 - 09:28 am
AstraZeneca
Farxiga
diabetes
7 Pharma Plays With Emerging Market Potential
Barron's
Wed, 03/22/17 - 10:59 pm
emerging markets
Pfizer
GSK
Sanofi
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Dr Reddy's
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Market Realist
Tue, 03/21/17 - 06:56 pm
Japan
AstraZeneca
Tagrisso
Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis
Fierce Pharma
Mon, 03/20/17 - 10:57 am
AstraZeneca
JNJ
Eli Lilly
Boehringer Ingelheim
diabetes
Farixga
Invokana
Jardiance
SGLT2 inhibitor
$230M deal: AstraZeneca forms COPD drugs collaboration
Bizjournals.com
Sat, 03/18/17 - 09:28 am
AstraZeneca
COPD
Circassia
Duaklir
Tudorza
FDA Rejects AstraZeneca’s Hyperkalemia Drug
Investopedia
Fri, 03/17/17 - 09:29 am
AstraZeneca
FDA
hyperkalemia
ZS-9
AZ gears up for FDA filing as PARP inhibitor Lynparza wins big in ovarian cancer trial
Fierce Pharma
Tue, 03/14/17 - 04:43 pm
AstraZeneca
PARP inhibitors
Lynparza
FDA
ovarian cancer
clinical trials
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
ertugliflozin
Jardiance
Boehringer Ingelheim
Eli Lilly
JNJ
Invokana
AstraZeneca
Farxiga
AstraZeneca CEO Soriot counts up £13.4M in 2016 pay, a 68% hike
Fierce Pharma
Wed, 03/8/17 - 05:32 pm
AstraZeneca
Pascal Soriot
Pharma CEOs
executive pay
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Endpoints
Fri, 03/3/17 - 09:24 am
Sanofi
AstraZeneca
RSV
MEDI8897
Emerging Markets Expected to Be AstraZeneca’s Key Growth Driver
Market Realist
Thu, 03/2/17 - 09:38 am
emerging markets
AstraZeneca
AstraZeneca Has Started a Turnaround
TheStreet.com
Mon, 02/27/17 - 10:14 pm
AstraZeneca
Nasal flu vaccine may not be recommended for use in US for years
Stat
Fri, 02/24/17 - 09:13 am
flu vaccines
nasal flu vaccine
FluMist
AstraZeneca
MedImmune
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
Fierce Pharma
Tue, 02/21/17 - 11:14 am
AstraZeneca
Zoladex
TerSera Therapeutics

Pages